|
Lost
opportunity?
Though there is nothing much to crib about, the Union Budget
had defied expectations that the industry had on reform. Katya
Naidu tries to understand Budget and its impact on the pharma
industry.
Upfront
Ethypharm
strikes deal with Shantha
Ethypharm India, the subsidiary of French Drug Delivery Company
Ethypharm SA, announced an out-licensing and supply contract
agreement for Ondansetron Flashtab with Shantha Biotechnics,
for India.
Strides
gets FDA nod for AIDS drugs
Strides Arcolab has received tentative approval from the USFDA
for Lamivudine/Zidovudine 150 mg/300 mg tablets co-packaged
with Nevirapine 200 mg tablets.
Granules
signs deal with Aussie company
Granules India announced that it has entered into an outsourcing
agreement with Matchland, (trading as New Products Development).
Under the agreement, New Products Development will outsource
its finished dosage manufacturing requirement to Granules
India for the Australian market.
The
chemistry of pharma
One again pharma industry rolled together for the lab management
conference held in Mumbai. The conference provided some interesting
insights into managing a lab.
On
a contract basis!
Mumbai struck a big deal on a contract basis when it hosted
the first annual contract manufacturing conference. India's
inherent cost competitiveness coupled with growth in generic
markets and the domestic demand because of improvement in
living standards has left no gaps in India a contract manufacturing
heaven.
Upcoming
Events
Crystallisation
tools for the research chemist
The need to study crystallisation is extremely widespread
in the chemical industry due to the importance of solids as
the final form of many products.
Products
|
